SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* SILLERMAN ROBERT F X (Last) (First) (Middle) 650 MADISON AVENUE (Street) NEW YORK NY 10022 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol CKX, Inc. [ CKXE ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner X Officer (give title below) Other (specify below) Chairman & CEO
	3. Date of Earliest Transaction (Month/Day/Year) 06/01/2007
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	07/18/2007		G		3,000,000(1)	D	$0	34,865,478(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to buy Series B Convertible Preferred Stock(3)	$15.3	06/01/2007		P		1,491,817		(3)	(3)	Series B Convert. Preferred Stock, par value $0.01 per share	1,491,817(4)	$0	1,491,817	I	see footnote(3)
Forward Contract (obligation to sell)	$12.82	07/18/2007		S			1	(5)	01/19/2008(5)	Common Stock, par value $0.01 per share	3,000,000	$38,460,000	0	I	see footnote(1)
Put (obligation to buy)	$13.75	07/18/2007		P		3,000,000		01/19/2008(6)	01/19/2008(6)	Common Stock, par value $0.01 per share	3,000,000	$41,250,000	3,000,000(7)	I	see foonote(1)

Explanation of Responses:

1. Mr. Sillerman transferred 3,000,000 shares of common stock of CKX, Inc. to the Tomorrow Foundation, a charity founded by Mr. Sillerman and Laura Baudo Sillerman, Mr. Sillerman's wife; Mr. Sillerman is a director of the Tomorrow Foundation.

2. includes (i) 1,000,000 shares of Common Stock owned of record by Laura Baudo Sillerman, Mr. Sillerman's spouse, (ii) 6,135,704 shares of Common Stock owned of record by Sillerman Commercial Holdings Partnership L.P., in which Mr. Sillerman is the sole stockholder of the general partner; (iii) 2,556,392 shares of Common Stock owned of record by Sillerman Capital Holdings, L.P., a limited partnership owned by Mr. Sillerman and a trust for the benefit of Mr. Sillerman's descendants; (iv) 3,000,000 shares of Common Stock owned of record by the Tomorrow Foundation, a charity founded by Mr. Sillerman and Laura Baudo Sillerman of which Mr. Sillerman is a director; and (v) 1,491,817 shares of Common Stock issuable upon conversion of 1,491,817 shares Series B Convertible Preferred Stock of CKX, Inc. that are subject to an option agreement entered into by 19X, Inc., a Delaware corporation owned by Mr. Sillerman and Simon Fuller, and The Promenade Trust.

3. 19X, Inc., a Delaware corporation wholly-owned by Simon Fuller and Robert F.X. Sillerman, entered into an agreement with The Promenade Trust on June 1, 2007 for an option to buy 1,491,817 shares of CKX Series B Convertible Preferred Stock, par value $0.01, currently owned by The Promenade Trust. The option must be exercised, if at all, no later than 15 days prior to the anticipated closing pursuant to the Agreement and Plan of Merger by and between CKX, Inc., 19X, Inc. and 19X Acquisition Corp, dated June 1, 2007. The closing is anticipated to occur in the fourth quarter of 2007.

4. The 1,491,817 shares of Series B Convertible Preferred Stock of CKX, Inc. are convertible into shares of common stock of CKX, Inc. on a one-for-one basis.

5. The Tomorrow Foundation entered into a forward contract with Bear Stearns International Limited ("Bear Stearns") on July 18, 2007 to sell 3,000,000 shares of common stock of CKX, Inc. to Bear Stearns. The prepayment date under the forward contract was July 20, 2007, and the settlement date is January 19, 2008.

6. The Tomorrow Foundation entered into a put agreement on July 18, 2007 with Bear Stearns whereby it agreed to purchase 3,000,000 shares of common stock of CKX, Inc. from Bear Stearns. The expiration date is January 19, 2008.

7. Does not include the 1,491,817 shares of Series B Convertible Preferred Stock of CKX, Inc. referred to in footnote (3) above.

	/s/ Robert F.X. Sillerman	07/20/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.